Givaudan

Rising Regulatory Scrutiny And Raw Material Costs Will Undermine Prospects

AnalystLowTarget

Not Invested

Community Contributor

Published

31 Aug 25

n/a

AnalystLowTarget's Fair Value

n/a

-10.0%

1.3%

-10.0%

1.3%

You can edit this narrative until Aug 31 10:09 PM. Then, changes will post as Updates.

Author's Valuation

CHF 3.2k6.2% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

CHF 3.2k

6.2% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.06%

Chemicals revenue growth rate

0.66%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

4.48%

Calculation

CHF 1.24b

Earnings '28

26.58x

PE Ratio '28

CHF 32.90b

Market Cap '28

CHF 32.90b

Market Cap '28

9.24m

No. shares '28

CHF 3.56k

Share Price '28

CHF 3.56k Share Price '28

Discounted to 2025 @ 4.54% p.a.

CHF 3.12k

Fair Value '25